期刊论文详细信息
BMC Pulmonary Medicine
The effectiveness of non-pharmacological healthcare interventions for asthma management during pregnancy: a systematic review
Johnson George2  Michael J Abramson1  Kay Stewart2  Elida Zairina2 
[1]Department of Allergy, Immunology and Respiratory Medicine, The Alfred Hospital, Melbourne, VIC, Australia
[2]Centre for Medicine Use and Safety, Monash University, Parkville, VIC, Australia
关键词: Pregnancy;    Management;    Interventions;    Non-pharmacological;    Asthma;   
Others  :  866439
DOI  :  10.1186/1471-2466-14-46
 received in 2013-12-12, accepted in 2014-03-07,  发布年份 2014
【 摘 要 】

Background

While reviews have been published on asthma management in pregnant women, none has examined the effectiveness of non-pharmacological healthcare interventions for optimizing asthma management in pregnant women. This systematic review aims to identify non-pharmacological healthcare interventions for optimizing asthma management during pregnancy and to examine their effects on maternal asthma control and neonatal outcomes.

Methods

The Cochrane Central Register of Controlled Trials (CENTRAL, Cochrane Library), MEDLINE, EMBASE, PsycINFO, CINAHL Plus and International Pharmaceutical Abstracts (IPA) were searched. Two reviewers independently assessed the identified studies against the eligibility criteria and extracted relevant information. The effects of the intervention were assessed qualitatively.

Results

Nine studies were identified, of which six were rejected according to the exclusion criteria. The three studies included in the final review described an education program, progressive muscle relaxation (PMR) and Fraction of exhaled Nitric Oxide (FeNO) guided management of asthma in pregnant women. The PMR and FeNO-guided interventions showed significant improvements in maternal asthma control (lung function and quality of life) and neonatal outcomes (birth weight).

Conclusions

Further evidence from well-designed studies evaluating non-pharmacological healthcare interventions for optimizing asthma management in pregnant women is required.

【 授权许可】

   
2014 Zairina et al.; licensee BioMed Central Ltd.

附件列表
Files Size Format View
Figure 5. 143KB Image download
60KB Image download
【 图 表 】

Figure 5.

【 参考文献 】
  • [1]Bousquet J, Khaltaev N: Global surveillance, prevention and control of chronic respiratory diease: a comprehensive approach 2007. Switzerland: World Health Organization; 2007.
  • [2]GINA Report: Global strategy for asthma management and prevention. 2010. From the Global Strategy for Asthma (GINA) http://www.ginasthma.org webcite
  • [3]Kwon HL, Triche EW, Belanger K, Bracken MB: The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am 2006, 26:29-62.
  • [4]Kwon H, Belanger K, Bracken M: Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys. Ann Epidemiol 2003, 13:317-324.
  • [5]Sawicki E, Stewart K, Wong S, Leung L, Paul E, George J: Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol 2011, 51:333-338.
  • [6]Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W, Zeiger RS: The course of asthma during pregnancy, post partum, and with successive pregnancies: a prospective analysis. J Allergy Clin Immunol 1988, 81:509-517.
  • [7]Sawicki E, Stewart K, Wong S, Paul E, Leung L, George J: Management of asthma by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol 2012, 52:183-188.
  • [8]Murphy VE, Wang G, Namazy JA, Powell H, Gibson PG, Chambers C, Schatz M: The risk of congenital malformations, perinatal mortality and neonatal hospitalisation among pregnant women with asthma: a systematic review and meta-analysis. BJOG 2013, 120:812-822.
  • [9]Namazy JA, Murphy VE, Powell H, Gibson PG, Chambers C, Schatz M: Effects of asthma severity, exacerbations and oral corticosteroids on perinatal outcomes. Eur Respir J 2013, 41:1082-1090.
  • [10]Wen SW, Demissie K, Liu S: Adverse outcomes in pregnancies of asthmatic women: results from a Canadian population. Ann Epidemiol 2001, 11:7-12.
  • [11]BTS 2007, British Thoracic Society, Scottish Intercollegiate Guideline Network: British guideline on the management of asthma 2007. [http://www.sign.ac.uk/guidelines]. Asthma in pregnancy. Thorax 2008, 63(Suppl 4):iv1-iv121.
  • [12]National Heart Lung, and Blood Institute: Managing special situations-pregnancy. In National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Rockville, MD: US Department of Health and Human Services NIH Publication; 2007:365-366.
  • [13]American College of Obstetrician & Gnyecologists (ACOG) and the American College of Allergy (ACAAI): Position statement: the use of newer asthma and allergy medications during pregnancy. Ann Allergy Asthma Immunol 2000, 84:475-480.
  • [14]National Asthma Council of Australia: Pregnancy and asthma. In Asthma Management Handbook. Melbourne: National Asthma Council Ltd; 2006:101-103.
  • [15]Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O’Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008, 31:143-178.
  • [16]Busse WW: NAEPP expert panel report: managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol 2005, 115:34-46.
  • [17]Guy ES, Kirumaki A, Hanania NA: Acute asthma in pregnancy. Crit Care Clin 2004, 20:731-745.
  • [18]Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, Bauman A, Hensley MJ, Walters EH: Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003, CD001117.
  • [19]Maselli DJ, Adams SG, Peters JI, Levine SM: Management of asthma during pregnancy. Ther Adv Respir Dis 2013, 7:87-100.
  • [20]Ostrom NK: Women with asthma: a review of potential variables and preferred medical management. Ann Allergy Asthma Immunol 2006, 96:655-665.
  • [21]Schatz M, Leibman C: Inhaled corticosteroid use and outcomes in pregnancy. Ann Allergy Asthma Immunol 2005, 95:234-238.
  • [22]Dombrowski MP, Schatz M, Wise R, Thom EA, Landon M, Mabie W, Newman RB, McNellis D, Hauth JC, Lindheimer M, Lindheimer M, Caritis SN, Leveno KJ, Meis P, Miodovnik M, Wapner RJ, Varner MW, O’Sullivan MJ, Conway DL: Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. Am J Obstet Gynecol 2004, 190:737-744.
  • [23]Lim AS, Stewart K, Abramson MJ, George J: Management of asthma in pregnant women by general practitioners: a cross sectional survey. BMC Fam Pract 2011, 12:1-7. BioMed Central Full Text
  • [24]Lim AS, Stewart K, Abramson MJ, Ryan K, George J: Asthma during pregnancy: the experiences, concerns and views of pregnant women with asthma. J Asthma 2012, 49:474-479.
  • [25]Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
  • [26]Marks GB, Dunn SM, Woolcock AJ: A scale for the measurement of quality of life in adults with asthma. J Clin Epidemiol 1992, 45:461-472.
  • [27]Higgins JPT, Green S: Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org/ webcite
  • [28]Lozano P: Interventions to improve the management of asthma in primary care settings (Protocol). Cochrane Database Syst Rev 2003. CD004537. doi:10.1002/14651858.CD004537
  • [29]Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535.
  • [30]Ziegler A: Asthma management during pregnancy. J Ark Med Soc 2005, 102:20-24.
  • [31]Charlton RA, Hutchison A, Davis KJ, de Vries CS: Asthma management in pregnancy. PLoS One 2013, 8:e60247.
  • [32]Tamasi L, Bohacs A, Bikov A, Andorka C, Rigo J Jr, Losonczy G, Horvath I: Exhaled nitric oxide in pregnant healthy and asthmatic women. J Asthma 2009, 46:786-791.
  • [33]Schatz M, Dombrowski MP, Wise R, Lai Y, Landon M, Newman RB, Rouse DJ, Miodovnik M, O'Sullivan MJ, Caritis SN, Leveno KJ, Wapner RJ, Conway DL: The relationship of asthma-specific quality of life during pregnancy to subsequent asthma and perinatal morbidity. J Asthma 2010, 47:46-50.
  • [34]Powell H, McCaffery K, Murphy VE, Hensley MJ, Clifton VL, Giles W, Gibson PG: Psychosocial outcomes are related to asthma control and quality of life in pregnant women with asthma. J Asthma 2011, 48:1032-1040.
  • [35]Powell H, McCaffery K, Murphy VE, Hensley MJ, Clifton VL, Giles W, Gibson PG: Psychosocial variables are related to future exacerbation risk and perinatal outcomes in pregnant women with asthma. J Asthma 2013, 50:383-389.
  • [36]Murphy VE, Gibson PG, Talbot PI, Kessell CG, Clifton VL: Asthma self-management skills and the use of asthma education during pregnancy. Eur Respir J 2005, 26:435-441.
  • [37]Nickel C, Lahmann C, Muehlbacher M, Pedrosa Gil F, Kaplan P, Buschmann W, Tritt K, Kettler C, Bachler E, Egger C, Anvar J, Fartacek R, Loew T, Rother W, Nickel M: Pregnant women with bronchial asthma benefit from progressive muscle relaxation: a randomized, prospective, controlled trial. Psychother Psychosom 2006, 75:237-243.
  • [38]Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, Gibson PG: Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet 2011, 378:983-990.
  • [39]Gibson PG, Ram FSF, Powell H: Asthma education. Respir Med 2003, 97:1036-1044.
  • [40]Huntley A, White AR, Ernst E: Relaxation therapies for asthma: a systematic review. Thorax 2002, 57:127-131.
  • [41]Hegewald MJ, Crapo RO: Respiratory physiology in pregnancy. Clin Chest Med 2011, 32:1-13. vii
  • [42]Wise RA, Polito AJ: Respiratory physiologic changes in pregnancy. Immunol Allergy Clin North Am 2000, 20:663-672.
  • [43]Bealert S, Greenberger PA: Chapter 16: asthma in pregnancy. Allergy Asthma Proc 2012, 33:55-57.
  • [44]Schatz M, Dombrowski MP, Wise R, Momirova V, Landon M, Mabie W, Newman RB, Rouse DJ, Lindheimer M, Miodovnik M, Caritis SN, Leveno KJ, Meis P, Wapner RJ, Paul RH, O’Sullivan MJ, Varner MW, Thurnau GR, Conway DL: Spirometry is related to perinatal outcomes in pregnant women with asthma. Am J Obstet Gynecol 2006, 194:120-126.
  • [45]NAEPP expert panel report: Report of The Working Group on Asthma and Pregnancy: Management of asthma during pregnancy. Bethesda (MD): US Department of Health and Human Services; national Institutes of Health; National Heart, Lung and Blood Institute, Maryland; 1993. [NIH Publication No.93-3279A] http://www.nhlbi.nih.gov/health/prof/lung/asthma/astpreg.txt webcite
  • [46]White RJ, Coutts II, Gibbs CJ, MacIntyre C: A prospective study of asthma during pregnancy and the puerperium. Respir Med 1989, 83:103-106.
  • [47]Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N: Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006, 129:1492-1499.
  • [48]Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID: The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007, 176:231-237.
  • [49]Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu AH, Wildfire JJ, Curry MD, Busse WW: Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008, 372:1065-1072.
  • [50]Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163-2173.
  • [51]Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR: An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011, 184:602-615.
  文献评价指标  
  下载次数:3次 浏览次数:11次